BofA: Investors pour into bonds, pull back from crypto
Coliseum Capital has significantly increased its stake in Owens & Minor Inc . (NYSE:OMI) with a series of stock purchases totaling $27.4 million. The transactions, which took place between February 28 and March 4, 2025, involved the acquisition of 2,892,412 shares at prices ranging from $9.19 to $9.75 per share.
The purchases were made by Coliseum Capital Management, LLC, Coliseum Capital, LLC, and Coliseum Capital Partners (WA:CPAP), L.P., along with Christopher Shackelton and Adam Gray, who are significant stakeholders in the investment firms. Following these transactions, the group now collectively holds 10,624,599 shares of Owens & Minor.
These acquisitions reflect Coliseum Capital’s continued interest in Owens & Minor, a company specializing in medical, dental, and hospital equipment and supplies. The purchases are part of Coliseum Capital’s investment strategy, as they hold more than ten percent ownership in the company.
In other recent news, Owens & Minor Inc. reported its fourth-quarter 2024 financial results, showcasing a better-than-expected earnings per share (EPS) of $0.55, surpassing the forecasted $0.54. However, the company’s revenue slightly missed expectations, coming in at $2.69 billion compared to the anticipated $2.73 billion. The company demonstrated a 1.5% year-over-year revenue increase, alongside a full-year adjusted EPS growth of 13%. Owens & Minor also announced a significant reduction in debt by $244 million for the year, totaling $647 million over the past two years. The company’s Patient Direct segment reported mid-single-digit growth, bolstered by innovations such as the Byram Connect digital health coach for diabetes. Additionally, Owens & Minor provided a 2025 revenue guidance range of $10.85 billion to $11.15 billion, with a midpoint of $11 billion. The company plans to pursue the acquisition of Rotech, which is expected to close in the first half of 2025, and anticipates cost synergies exceeding $50 million. Furthermore, Owens & Minor’s Board of Directors has authorized a share repurchase program of up to $100 million, reflecting strategic capital deployment priorities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.